Cargando…
The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo
BACKGROUND: Colorectal cancer is the third most common cancer worldwide; and in 40% of all cases, KRAS4b-activating mutations occur. KRAS4b is transported by phosphodiesterase-6δ (PDEδ) to the plasma membrane, where it gets activated. PDEδ downregulation prevents redistribution and activation of KRA...
Autores principales: | Cruz-Nova, Pedro, Schnoor, Michael, Correa-Basurto, José, Bello, Martiniano, Briseño-Diaz, Paola, Rojo-Domínguez, Arturo, Ortiz-Mendoza, Carlos M., Guerrero-Aguirre, Jorge, García-Vázquez, Francisco J., Hernández-Rivas, Rosaura, Thompson-Bonilla, María del Rocío, Vargas, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211466/ https://www.ncbi.nlm.nih.gov/pubmed/30382908 http://dx.doi.org/10.1186/s12885-018-4968-3 |
Ejemplares similares
-
KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer
por: Casique-Aguirre, Diana, et al.
Publicado: (2018) -
Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer
por: Briseño-Díaz, Paola, et al.
Publicado: (2023) -
(131)I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry
por: Cruz-Nova, Pedro, et al.
Publicado: (2022) -
Development of PD3 and PD3-B for PDEδ inhibition to modulate KRAS activity
por: Lee, Jungeun, et al.
Publicado: (2022) -
Molecular Dynamics Simulations to Provide Insights into Epitopes Coupled to the Soluble and Membrane-Bound MHC-II Complexes
por: Bello, Martiniano, et al.
Publicado: (2013)